7T磁共振波谱成像揭示复发缓解型多发性硬化病灶特异性代谢改变
本研究对51例复发缓解型多发性硬化患者进行7T磁共振波谱成像,评估常规MRI可见与不可见病灶内部及周围的局灶代谢改变,并与T1低信号及病灶至皮质灰质距离进行相关性分析。研究发现常规MRI不可见的代谢热点(mIns/tNAA较周围正常表现白质平均高2.8倍),且T1弛豫与mIns/tNAA正相关、与tNAA/tCr和tCho/tCr负相关,提示MRSI可作为早期生物标志物成像病灶发展。
要点
- 7T MRSI可显示常规MRI不可见的局灶代谢异常,表现为mIns/tNAA升高。
- T1弛豫与mIns/tNAA正相关,与tNAA/tCr、tCho/tCr负相关。
- 靠近皮质灰质的病灶mIns/tCr较低,提示代谢改变与病灶位置相关。
核心结论
- 7T MRSI可在体内显示常规MRI不可见的局灶性多发性硬化病理改变,并评估病灶中心、活动性病灶周边及皮质病灶的代谢物水平。
- MRSI有望将mIns作为病灶发展的早期生物标志物进行成像。
研究设计与样本
- 研究为对51例复发缓解型多发性硬化患者(30女/21男,平均年龄35.4±9.9岁)进行的7T磁共振波谱成像研究。
- 计算正常表现白质、白质病灶及常规MRI不可见的mIns/tNAA增高局灶区域的平均代谢物比值。
- 根据T1弛豫和至皮质灰质距离进行亚组分析,并将代谢物比值与T1进行相关性分析及比较常规MRI可见病灶周围不同层。
关键影像表现/征象
- 发现平均mIns/tNAA较周围正常表现白质高2.8倍、表现类似多发性硬化病灶的局灶区域,这些区域在常规MRI上不可见(约占代谢热点的4%)。
- T1弛豫与mIns/tNAA呈正相关(P≤0.01),与tNAA/tCr(P≤0.01)和tCho/tCr(P≤0.01)呈负相关。
- 病灶外mIns/tCr增高,而tNAA/tCr分布类似病灶内宏观组织损伤。
- 靠近皮质灰质的病灶mIns/tCr低21%(P≤0.05)。
临床应用与阅片要点
- 日常阅片可关注7T MRSI显示的常规MRI不可见代谢热点,提示早期病灶活动。
- 结合T1弛豫和病灶至皮质灰质距离,评估代谢改变的空间异质性。
局限性
- 研究为单中心设计,样本量51例,结论需多中心验证。
- 仅纳入复发缓解型多发性硬化患者,未涵盖其他亚型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Magnetic resonance spectroscopic imaging (MRSI) of the brain enables in vivo assessment of metabolic alterations in multiple sclerosis (MS). This provides complementary insights into lesion pathology that cannot be obtained via T1- and T2-weighted conventional magnetic resonance imaging (cMRI).
PURPOSE: The aims of this study were to assess focal metabolic alterations inside and at the periphery of lesions that are visible or invisible on cMRI, and to correlate their metabolic changes with T1 hypointensity and the distance of lesions to cortical gray matter (GM).
METHODS: A 7 T MRSI was performed on 51 patients with relapsing-remitting MS (30 female/21 male; mean age, 35.4 ± 9.9 years). Mean metabolic ratios were calculated for segmented regions of interest (ROIs) of normal-appearing white matter, white matter lesions, and focal regions of increased mIns/tNAA invisible on cMRI. A subgroup analysis was performed after subdividing based on T1 relaxation and distance to cortical GM. Metabolite ratios were correlated with T1 and compared between different layers around cMRI-visible lesions.
RESULTS: Focal regions of, on average, 2.8-fold higher mIns/tNAA than surrounding normal-appearing white matter and with an appearance similar to that of MS lesions were found, which were not visible on cMRI (ie, ~4% of metabolic hotspots). T1 relaxation was positively correlated with mIns/tNAA ( P ≤ 0.01), and negatively with tNAA/tCr ( P ≤ 0.01) and tCho/tCr ( P ≤ 0.01). mIns/tCr was increased outside lesions, whereas tNAA/tCr distributions resembled macroscopic tissue damage inside the lesions. mIns/tCr was -21% lower for lesions closer to cortical GM ( P ≤ 0.05).
CONCLUSIONS: 7 T MRSI allows in vivo visualization of focal MS pathology not visible on cMRI and the assessment of metabolite levels in the lesion center, in the active lesion periphery and in cortical lesions. This demonstrated the potential of MRSI to image mIns as an early biomarker in lesion development.
引用
- Lipka, Niess, Dal-Bianco, et al. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging. Invest Radiol. 2022. PMID: 36094811. doi:10.1097/RLI.0000000000000913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。